OMER Key Stats
- Omeros to Present at Two Upcoming Conferences PR Newswire May 22
- Traders in Omeros Attributing Upside in Shares to Bullish Note from MLV & Co., S... May 14
- Omeros Announces Closing of $16.2 Million Registered Direct Offering of Common S... May 14
- Investors are Digesting These Healthcare Stock Earnings Insights May 12
- Short Interest Jumps 41.2% For OMER May 10
- OMEROS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Othe... May 10
- Omeros Corporation Reports First Quarter 2013 Financial Results PR Newswire May 10
- Omeros Announces 3.9M Share Direct Offering of Common Stock at $4.14/Share Benzinga May 9
- Omeros Announces $16.2 Million Registered Direct Offering of Common Stock PR Newswire May 9
- Omeros Earnings: Everything You Must Know Now May 9
OMER Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Omeros Corporation is down 48.97% over the last year vs S&P 500 Total Return up 28.68%, Alexion Pharmaceuticals up 13.32%, and Targacept up 29.25%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for OMER
Pro Report PDF for OMER
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download OMER Pro Report PDF
Pro Strategies Featuring OMER
Did Omeros Corporation make it into our Pro Portfolio Strategies?